首页> 外文期刊>Hybridoma and hybridomics >Production of monoclonal antibody inhibiting dipeptidy-laminopeptidase IV activity of Porphyromonas gingivalis.
【24h】

Production of monoclonal antibody inhibiting dipeptidy-laminopeptidase IV activity of Porphyromonas gingivalis.

机译:抑制牙龈卟啉单胞菌的二肽-laminopeptidase IV活性的单克隆抗体的生产。

获取原文
获取原文并翻译 | 示例
       

摘要

Porphyromonas gingivalis is a Gram-negative anaerobic bacterial species implicated as an important pathogen in the development of adult periodontitis. We previously cloned a gene encoding dipeptydilaminopeptidase IV (DAPIV) from P. gingivalis. In the present study, for immunological diagnosis and development of passive immunization, we produced a mouse monoclonal antibody (MAb) capable of inhibiting the DAPIV activity of P. gingivalis using highly purified recombinant DAPIV as an immunogen. The constructed MAb, designated as MAb-Pg-DAP-1, significantly inhibited DAPIV activity in P. gingivalis, as well as slightly inhibited that in other gram-negative bacteria such as Porphyromonas endodontalis and Prevotella loesheii, whereas no inhibition was seen in the gram-positive bacteria Streptococcus mutans and Actinomyces viscosus. Furthermore, the MAb did not inhibit DAPIV enzyme activity in human serum. This novel MAb may be useful for the development of immunological diagnosis capability and in passive immunization.
机译:牙龈卟啉单胞菌是革兰氏阴性厌氧细菌,在成人牙周炎的发展中被认为是重要的病原体。我们先前克隆了来自牙龈卟啉单胞菌的编码二肽二氨基肽酶IV(DAPIV)的基因。在本研究中,对于免疫诊断和被动免疫的发展,我们使用高度纯化的重组DAPIV作为免疫原,生产了能够抑制牙龈卟啉单胞菌DAPIV活性的小鼠单克隆抗体(MAb)。所构建的MAb命名为MAb-Pg-DAP-1,可显着抑制牙龈卟啉单胞菌中的DAPIV活性,并略微抑制其他革兰氏阴性细菌(如牙菌卟啉单胞菌和普氏菌)中的DAPIV活性,而在革兰氏阳性细菌变形链球菌和粘性放线菌。此外,MAb不会抑制人血清中的DAPIV酶活性。这种新的单克隆抗体可用于发展免疫学诊断能力和被动免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号